← Back to Search

Prebiotic

Acetylated and Butyrylated High Amylose Maize Starch for Type 1 Diabetes

Phase 3
Waitlist Available
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 12 weeks
Awards & highlights

Study Summary

This trial will test whether a prebiotic called HAMS-AB can help prevent type 1 diabetes by improving the gut microbiome and glycemia in humans.

Eligible Conditions
  • Type 1 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in the gut microbiome profile
Secondary outcome measures
Changes in Beta cell Health.
Changes in Glycemia.
Changes in the Short Chain Fatty Acid Levels in the Gut.
Other outcome measures
Changes in frequency of Mucosal Associated invariant T (MAIT) cells
Changes in function of Mucosal Associated invariant T (MAIT) cells
Changes in phenotype of Mucosal Associated invariant T (MAIT) cells

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention GroupExperimental Treatment1 Intervention
This arm will consume the supplement daily for 4 weeks.
Group II: Control GroupActive Control1 Intervention
This arm will not receive the supplement for 4 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Acetylated and Butyrylated High Amylose Maize Starch
2020
Completed Phase 3
~10

Find a Location

Who is running the clinical trial?

Indiana UniversityLead Sponsor
984 Previous Clinical Trials
1,080,332 Total Patients Enrolled
National Center for Advancing Translational Sciences (NCATS)NIH
322 Previous Clinical Trials
401,512 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Will people who are more than 50 years old be able to participate in this research project?

"According to the age requirements set out by the trial's inclusion criteria, potential participants must be betwen 11 and 17."

Answered by AI

Is there any danger to consumers associated with Acetylated and Butyrylated High Amylose Maize Starch?

"Acetylated and Butyrylated High Amylose Maize Starch is being trialed in Phase 3, meaning that while there is data supporting efficacy, there is also multiple rounds of data supporting safety. Our team has estimated the safety to be a 3 on a scale from 1 to 3."

Answered by AI

To whom does this experiment offer the chance for inclusion?

"This trial is looking for 12 child participants, aged 11-17, who currently have diabetes and autoimmune diseases. Additionally, it is important that potential participants meet the following requirements: Be willing to use contraception if sexually active, have a BMI lower than 85% for their age and sex, test positive for any of the diabetes-related autoantibodies [insulin autoantibody (if tested within 14 days of diagnosis), glutamic acid decarboxylase (GAD), insulinoma-associated protein-2 (IA-2), or Zinc transporter 8 autoantibodies (ZnT8)], be willing"

Answered by AI

Are there any other notable scientific papers that mention Acetylated and Butyrylated High Amylose Maize Starch?

"There are currently 8 Acetylated and Butyrylated High Amylose Maize Starch clinical trials underway. Out of these 8, 2 have progressed to Phase 3 testing. Most of the Chapel Hill, North carolina based trials are for this treatment, but there are a total of 14 facilities running these types of trials."

Answered by AI
~1 spots leftby May 2025